A game changer for personalised medicine?
Daniel Streetman PharmD, MS of Wolters Kluwer, Health, discusses the potential for pharmacogenomics to transform the efficacy of prescribed drugs and reduce instances of adverse drug reactions. He also explores the professional, ethical and logistical challenges that still need to be overcome for genomics to achieve widespread traction in the UK.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.